Published in J Virol on March 01, 2005
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev (2005) 3.18
A contemporary view of coronavirus transcription. J Virol (2006) 2.47
Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog (2007) 1.78
Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positive-stranded RNA viruses. Nat Med (2013) 1.55
Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog (2005) 1.52
Severe acute respiratory syndrome coronavirus infection of mice transgenic for the human Angiotensin-converting enzyme 2 virus receptor. J Virol (2006) 1.49
Selective replication of coronavirus genomes that express nucleocapsid protein. J Virol (2005) 1.44
Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-like supergroup. J Virol (2008) 1.28
An improved reverse genetics system for mammalian orthoreoviruses. Virology (2009) 1.28
An interaction between the nucleocapsid protein and a component of the replicase-transcriptase complex is crucial for the infectivity of coronavirus genomic RNA. J Virol (2010) 1.10
Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome. J Virol (2007) 1.09
Recovery of a neurovirulent human coronavirus OC43 from an infectious cDNA clone. J Virol (2006) 1.06
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J Virol (2009) 1.06
Genome organization and reverse genetic analysis of a type I feline coronavirus. J Virol (2007) 0.96
Targeting membrane-bound viral RNA synthesis reveals potent inhibition of diverse coronaviruses including the middle East respiratory syndrome virus. PLoS Pathog (2014) 0.93
Reverse genetics of SARS-related coronavirus using vaccinia virus-based recombination. PLoS One (2012) 0.91
The nsp3 macrodomain promotes virulence in mice with coronavirus-induced encephalitis. J Virol (2014) 0.89
Structures of the N- and C-terminal domains of MHV-A59 nucleocapsid protein corroborate a conserved RNA-protein binding mechanism in coronavirus. Protein Cell (2010) 0.85
A new cistron in the murine hepatitis virus replicase gene. J Virol (2010) 0.84
Coronavirus reverse genetic systems: infectious clones and replicons. Virus Res (2014) 0.84
A systems immunology approach to plasmacytoid dendritic cell function in cytopathic virus infections. PLoS Pathog (2010) 0.84
Characterization of a critical interaction between the coronavirus nucleocapsid protein and nonstructural protein 3 of the viral replicase-transcriptase complex. J Virol (2013) 0.83
Attenuation of mouse hepatitis virus by deletion of the LLRKxGxKG region of Nsp1. PLoS One (2013) 0.83
High-Resolution Analysis of Coronavirus Gene Expression by RNA Sequencing and Ribosome Profiling. PLoS Pathog (2016) 0.78
Suppression subtractive hybridization method for the identification of a new strain of murine hepatitis virus from xenografted SCID mice. Arch Virol (2015) 0.75
Early endonuclease-mediated evasion of RNA sensing ensures efficient coronavirus replication. PLoS Pathog (2017) 0.75
A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med (2003) 29.55
Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Virus-encoded proteinases and proteolytic processing in the Nidovirales. J Gen Virol (2000) 4.83
Systematic assembly of a full-length infectious cDNA of mouse hepatitis virus strain A59. J Virol (2002) 4.29
Retargeting of coronavirus by substitution of the spike glycoprotein ectodomain: crossing the host cell species barrier. J Virol (2000) 3.46
The group-specific murine coronavirus genes are not essential, but their deletion, by reverse genetics, is attenuating in the natural host. Virology (2002) 2.72
Infectious RNA transcribed in vitro from a cDNA copy of the human coronavirus genome cloned in vaccinia virus. J Gen Virol (2001) 2.36
Enhanced growth of a murine coronavirus in transformed mouse cells. Infect Immun (1972) 2.35
Repair and mutagenesis of the genome of a deletion mutant of the coronavirus mouse hepatitis virus by targeted RNA recombination. J Virol (1992) 2.20
Reverse genetics system for the avian coronavirus infectious bronchitis virus. J Virol (2001) 2.19
Optimization of targeted RNA recombination and mapping of a novel nucleocapsid gene mutation in the coronavirus mouse hepatitis virus. J Virol (1994) 2.09
Characterization of the RNA components of a putative molecular switch in the 3' untranslated region of the murine coronavirus genome. J Virol (2004) 1.85
The RNA structures engaged in replication and transcription of the A59 strain of mouse hepatitis virus. J Gen Virol (2001) 1.66
Experimental demyelination produced by the A59 strain of mouse hepatitis virus. Neurology (1984) 1.64
Cooperation of an RNA packaging signal and a viral envelope protein in coronavirus RNA packaging. J Virol (2001) 1.56
Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus. J Virol (2000) 1.55
A hepatitis virus complicating studies with mouse leukemia. J Natl Cancer Inst (1961) 1.45
Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J Virol (2003) 1.41
A cellular J-domain protein modulates polyprotein processing and cytopathogenicity of a pestivirus. J Virol (2001) 1.35
Cleavage between replicase proteins p28 and p65 of mouse hepatitis virus is not required for virus replication. J Virol (2004) 1.32
Mouse hepatitis virus. Curr Opin Microbiol (2001) 1.31
Limbic encephalitis after inhalation of a murine coronavirus. Lab Invest (1988) 1.31
The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol (2003) 1.26
Coronaviruses as vectors: position dependence of foreign gene expression. J Virol (2003) 1.25
Vaccinia virus DNA ligase is nonessential for virus replication: recovery of plasmids from virus-infected cells. Virology (1991) 1.16
Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombination-independent selectable cloning vectors. Virology (1992) 1.13
Effective amplification of 20-kb DNA by reverse transcription PCR. Anal Biochem (1997) 1.08
Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol (2004) 1.07
The 3' cis-acting genomic replication element of the severe acute respiratory syndrome coronavirus can function in the murine coronavirus genome. J Virol (2004) 1.06
Multigene RNA vector based on coronavirus transcription. J Virol (2003) 1.03
Identification of the mutations responsible for the phenotype of three MHV RNA-negative ts mutants. Adv Exp Med Biol (2001) 0.94
Receptor-dependent coronavirus infection of dendritic cells. J Virol (2004) 0.93
Enterotropic coronavirus (mouse hepatitis virus) in mice: influence of host age and strain on infection and disease. Lab Anim Sci (1993) 0.86
A combination of mutations in the S1 part of the spike glycoprotein gene of coronavirus MHV-A59 abolishes demyelination. J Neurovirol (2004) 0.81
Acute hepatic failure in IFN-gamma-deficient BALB/c mice after murine coronavirus infection. Virus Res (2002) 0.81
Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol (2003) 9.09
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC. Nature (2013) 6.39
Mechanisms and enzymes involved in SARS coronavirus genome expression. J Gen Virol (2003) 4.66
Temporal dynamics of the human vaginal microbiota. Sci Transl Med (2012) 4.58
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature (2010) 3.49
Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol (2011) 2.85
Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med (2013) 2.70
Control of coronavirus infection through plasmacytoid dendritic-cell-derived type I interferon. Blood (2006) 2.53
A contemporary view of coronavirus transcription. J Virol (2006) 2.47
Microbial reefs in the Black Sea fueled by anaerobic oxidation of methane. Science (2002) 2.45
Major genetic marker of nidoviruses encodes a replicative endoribonuclease. Proc Natl Acad Sci U S A (2004) 2.41
Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Int J Surg Pathol (2008) 2.33
Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. EMBO J (2002) 2.30
Multiple enzymatic activities associated with severe acute respiratory syndrome coronavirus helicase. J Virol (2004) 2.29
Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential. MBio (2013) 2.17
Maturation of lymph node fibroblastic reticular cells from myofibroblastic precursors is critical for antiviral immunity. Immunity (2013) 1.89
Coronavirus non-structural protein 1 is a major pathogenicity factor: implications for the rational design of coronavirus vaccines. PLoS Pathog (2007) 1.78
Expression of miR-21 and its targets (PTEN, PDCD4, TM1) in flat epithelial atypia of the breast in relation to ductal carcinoma in situ and invasive carcinoma. BMC Cancer (2009) 1.70
Microglia in diseases of the central nervous system. Ann Med (2002) 1.66
Plasmacytoid dendritic cells control T-cell response to chronic viral infection. Proc Natl Acad Sci U S A (2012) 1.56
Isolation and characterization of a novel oncogene, amplified in liver cancer 1, within a commonly amplified region at 1q21 in hepatocellular carcinoma. Hepatology (2008) 1.54
Activation of the cholinergic anti-inflammatory system by nicotine attenuates neuroinflammation via suppression of Th1 and Th17 responses. J Immunol (2009) 1.53
Functional and genetic analysis of coronavirus replicase-transcriptase proteins. PLoS Pathog (2005) 1.52
Tumor-derived matrix metalloproteinase-13 (MMP-13) correlates with poor prognoses of invasive breast cancer. BMC Cancer (2008) 1.50
Multifocal stroke from tumor emboli. Arch Neurol (2009) 1.48
MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN. Carcinogenesis (2012) 1.47
Overexpression of eukaryotic initiation factor 5A2 enhances cell motility and promotes tumor metastasis in hepatocellular carcinoma. Hepatology (2010) 1.47
Isolation and characterization of current human coronavirus strains in primary human epithelial cell cultures reveal differences in target cell tropism. J Virol (2013) 1.47
CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc Natl Acad Sci U S A (2011) 1.47
HAb18G (CD147), a cancer-associated biomarker and its role in cancer detection. Histopathology (2009) 1.45
Type I IFN-mediated protection of macrophages and dendritic cells secures control of murine coronavirus infection. J Immunol (2009) 1.45
Selective replication of coronavirus genomes that express nucleocapsid protein. J Virol (2005) 1.44
CD8⁺ cytotoxic T cell and FOXP3⁺ regulatory T cell infiltration in relation to breast cancer survival and molecular subtypes. Breast Cancer Res Treat (2011) 1.43
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronaviruses. EMBO J (2013) 1.40
Aurora-B mediated ATM serine 1403 phosphorylation is required for mitotic ATM activation and the spindle checkpoint. Mol Cell (2011) 1.40
COOH-terminal truncated HBV X protein plays key role in hepatocarcinogenesis. Clin Cancer Res (2008) 1.34
Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells. Genes Cancer (2011) 1.32
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells. Hum Mol Genet (2002) 1.32
Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. Oncol Rep (2010) 1.28
Mouse hepatitis virus liver pathology is dependent on ADP-ribose-1''-phosphatase, a viral function conserved in the alpha-like supergroup. J Virol (2008) 1.28
Guidelines on the diagnosis and treatment of breast cancer (2011 edition). Gland Surg (2012) 1.25
Fibroblast growth factor receptor 2-positive fibroblasts provide a suitable microenvironment for tumor development and progression in esophageal carcinoma. Clin Cancer Res (2009) 1.24
Molecular preservation of the pigment melanin in fossil melanosomes. Nat Commun (2012) 1.24
Oncogenic function of microtubule end-binding protein 1 in breast cancer. J Pathol (2010) 1.22
Reduction of Akt2 inhibits migration and invasion of glioma cells. Int J Cancer (2009) 1.22
Somatic mutations of the mixed-lineage leukemia 3 (MLL3) gene in primary breast cancers. Pathol Oncol Res (2010) 1.18
A model of cancer stem cells derived from mouse induced pluripotent stem cells. PLoS One (2012) 1.17
Identification of PTK6, via RNA sequencing analysis, as a suppressor of esophageal squamous cell carcinoma. Gastroenterology (2012) 1.16
Activation of the ATM-Snail pathway promotes breast cancer metastasis. J Mol Cell Biol (2012) 1.16
Role for nsP2 proteins in the cessation of alphavirus minus-strand synthesis by host cells. J Virol (2006) 1.15
Invasive micropapillary carcinoma of the breast: association of pathologic features with lymph node metastasis. Am J Clin Pathol (2006) 1.15
Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro. J Virol (2005) 1.15
Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. PLoS Pathog (2013) 1.14
The SARS-coronavirus-host interactome: identification of cyclophilins as target for pan-coronavirus inhibitors. PLoS Pathog (2011) 1.14
Multinodular and vacuolating neuronal tumors of the cerebrum: 10 cases of a distinctive seizure-associated lesion. Brain Pathol (2013) 1.13
Characteristics and prognosis for molecular breast cancer subtypes in Chinese women. J Surg Oncol (2009) 1.12
Involvement of skeletal muscle in dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy). Muscle Nerve (2004) 1.12
MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract (2013) 1.12
Human coronavirus 229E papain-like proteases have overlapping specificities but distinct functions in viral replication. J Virol (2007) 1.12
A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer. Cancer Res (2013) 1.12
Twice-daily application of HIV microbicides alter the vaginal microbiota. MBio (2012) 1.11
Functional analysis of nsP3 phosphoprotein mutants of Sindbis virus. J Virol (2003) 1.10
Rab25 is a tumor suppressor gene with antiangiogenic and anti-invasive activities in esophageal squamous cell carcinoma. Cancer Res (2012) 1.09
Genetic interactions between an essential 3' cis-acting RNA pseudoknot, replicase gene products, and the extreme 3' end of the mouse coronavirus genome. J Virol (2007) 1.09
Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R. J Virol (2003) 1.09
TMPRSS2 activates the human coronavirus 229E for cathepsin-independent host cell entry and is expressed in viral target cells in the respiratory epithelium. J Virol (2013) 1.08
Chromodomain helicase/adenosine triphosphatase DNA binding protein 1-like (CHD1l) gene suppresses the nucleus-to-mitochondria translocation of nur77 to sustain hepatocellular carcinoma cell survival. Hepatology (2009) 1.08
Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA. J Gen Virol (2004) 1.07
High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Res (2006) 1.06
Organ-specific attenuation of murine hepatitis virus strain A59 by replacement of catalytic residues in the putative viral cyclic phosphodiesterase ns2. J Virol (2009) 1.06
Notch1 is involved in migration and invasion of human breast cancer cells. Oncol Rep (2011) 1.05
Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome (2013) 1.04
Suppression of neuroinflammation and immunomodulation by the acetylcholinesterase inhibitor rivastigmine. J Neuroimmunol (2008) 1.03
Induction of AApoAII amyloidosis by various heterogeneous amyloid fibrils. FEBS Lett (2004) 1.03
Multigene RNA vector based on coronavirus transcription. J Virol (2003) 1.03
Slit2/Robo1 signaling in glioma migration and invasion. Neurosci Bull (2010) 1.02
The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells. Carcinogenesis (2013) 1.01
Genomic RNA sequence of Feline coronavirus strain FIPV WSU-79/1146. J Gen Virol (2005) 1.01
The circulating glycosaminoglycan signature of respiratory failure in critically ill adults. J Biol Chem (2014) 1.00
Parkin regulates paclitaxel sensitivity in breast cancer via a microtubule-dependent mechanism. J Pathol (2009) 1.00
Characterization of White bream virus reveals a novel genetic cluster of nidoviruses. J Virol (2006) 1.00
Down-regulation of tumor suppressor gene FEZ1/LZTS1 in breast carcinoma involves promoter methylation and associates with metastasis. Breast Cancer Res Treat (2008) 1.00
Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis. BMC Med (2012) 0.98
Genomic RNA sequence of feline coronavirus strain FCoV C1Je. J Feline Med Surg (2007) 0.98
Reduction of protein kinase C zeta inhibits migration and invasion of human glioblastoma cells. J Neurochem (2009) 0.98
High-level SLP-2 expression and HER-2/neu protein expression are associated with decreased breast cancer patient survival. Am J Clin Pathol (2007) 0.98
N-linked glycosylation is essential for the stability but not the signaling function of the interleukin-6 signal transducer glycoprotein 130. J Biol Chem (2009) 0.98
Single-nucleotide polymorphism-mass array reveals commonly deleted regions at 3p22 and 3p14.2 associate with poor clinical outcome in esophageal squamous cell carcinoma. Int J Cancer (2008) 0.97